Predictive Oncology Inc (POAI)
Official siteHEALTH INFORMATION SERVICES
Last updated: Nov 13, 2026 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 22.3% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 44.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about POAI
News
No news available
Company news will appear here when available
POAI Valuation
- P/B
- -0.1x
POAI Profitability: Margins, ROIC and FCF
Predictive Oncology Competitors
Peers by sector and size for Predictive Oncology (POAI) include Jaguar Animal Health, Sonoma Pharmaceuticals and Cardio Diagnostics Holdings.
Sector: Healthcare
POAI Bull Case vs Bear Case
Bear case
- POAI beat EPS estimates in 12.5% of its last 8 reported quarters.
POAI Earnings: Beat Rate
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -193.5%
POAI Earnings Call
The latest POAI earnings call transcript on file is labeled 2024Q2.
Read the 2024Q2 transcriptUpdated Nov 20, 2025. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About POAI
Does POAI pay dividends?
Predictive Oncology Inc (POAI) does not currently pay a regular dividend.
POAI pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.